Literature DB >> 9357992

Inhibition of DNA synthesis and tube morphogenesis of cultured vascular endothelial cells by chondromodulin-I.

Y Hiraki1, T Kono, M Sato, C Shukunami, J Kondo.   

Abstract

Cartilage is an avascular tissue, and exhibits anti-angiogenic properties. Cartilage extracts have been shown to contain an inhibitor for DNA synthesis in vascular endothelial cells in vitro. Here we purified the inhibitory activity in the 10-50 kDa fraction of guanidine extracts from fetal bovine epiphyseal cartilage, and found that the inhibitor was identical with chondromodulin-I (ChM-I). Purified ChM-I inhibited tube morphogenesis of cultured vascular endothelial cells, as well as DNA synthesis. These results indicate that cartilage-specific glycoprotein ChM-I may participate in the maintenance of avascularity and anti-angiogenic properties of cartilage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357992     DOI: 10.1016/s0014-5793(97)01151-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  An anteroposterior wave of vascular inhibitor downregulation signals aortae fusion along the embryonic midline axis.

Authors:  Robert J Garriock; Catherine Czeisler; Yasuo Ishii; Alicia M Navetta; Takashi Mikawa
Journal:  Development       Date:  2010-11       Impact factor: 6.868

2.  A functional role of the glycosylated N-terminal domain of chondromodulin-I.

Authors:  Jun Kondo; Hiroyuki Shibata; Shigenori Miura; Akira Yamakawa; Koji Sato; Yoshiki Higuchi; Chisa Shukunami; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2010-05-27       Impact factor: 2.626

Review 3.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

4.  Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis.

Authors:  K Kusafuka; Y Hiraki; C Shukunami; A Yamaguchi; T Kayano; T Takemura
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Franck P Luyten; Raymond De Bondt; Yuji Hiraki; Chisa Shukunami; Teruo Kayano; Tamiko Takemura
Journal:  Virchows Arch       Date:  2003-04-18       Impact factor: 4.064

6.  4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.

Authors:  Dimitrios Stagos; Hongfei Zhou; David Ross; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

7.  Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation.

Authors:  Michael Bressan; Patricia Davis; John Timmer; Doris Herzlinger; Takashi Mikawa
Journal:  Dev Biol       Date:  2008-11-12       Impact factor: 3.582

8.  Chondromodulin I is a bone remodeling factor.

Authors:  Yuko Nakamichi; Chisa Shukunami; Takashi Yamada; Ken-ichi Aihara; Hirotaka Kawano; Takashi Sato; Yuriko Nishizaki; Yoko Yamamoto; Masayo Shindo; Kimihiro Yoshimura; Takashi Nakamura; Naoyuki Takahashi; Hiroshi Kawaguchi; Yuji Hiraki; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

9.  Chondromodulin I is dispensable during enchondral ossification and eye development.

Authors:  Oliver Brandau; Attila Aszódi; Ernst B Hunziker; Peter J Neame; Dietmar Vestweber; Reinhard Fässler
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Expression and localization of cartilage-specific matrix protein chondromodulin-I mRNA in salivary pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Keisuke Nakano; Yuji Hiraki; Chisa Shukunami; Hitoshi Nagatsuka; Noriyuki Nagai; Tamiko Takemura; Yutaku Sakaguchi; Kazuichi Okazaki; Michi Kusafuka; Hiroko Hisha; Susumu Ikehara
Journal:  Virchows Arch       Date:  2004-11-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.